GlassScriptPhysician profile
Shady Hammoud
NPI 1215461082
$3,768.49
in general payments reported to CMS, 2019-2025
20 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $234 · 2021: $1,219 · 2022: $1,063 · 2023: $543 · 2024: $381 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.34 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,154.47 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $499.33 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $405.58 | 2020-2025 | Breztri |
| Lilly USA, LLC | $335.13 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Cardinal Health 110 LLC | $200.00 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.96 | 2021-2023 | |
| Pfizer INC. | $182.23 | 2021-2023 | |
| Vivus LLC | $108.69 | 2020 | |
| Amag Pharmaceuticals, INC. | $107.84 | 2021 | |
| Pharmacosmos Therapeutics INC. | $106.41 | 2021 | |
| Abbvie INC. | $98.59 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.48 | 2022-2023 | Xifaxan |
| Amgen INC. | $79.88 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $63.22 | 2021-2024 | Xarelto |
| Dexcom, INC. | $47.44 | 2022-2023 | Dexcom G6 Transmitter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $32.22 | 2023-2025 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $27.08 | 2022 | |
| Abbott Laboratories | $17.64 | 2024 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $13.35 | 2022 | |
| Sanofi Pasteur INC. | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shady Hammoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.